The Potential of Induced Pluripotent Stem Cells to Advance the Treatment of Pancreatic Ductal Adenocarcinoma

The Potential of Induced Pluripotent Stem Cells to Advance the Treatment of Pancreatic Ductal Adenocarcinoma

Advances in the treatment of pancreatic ductal adenocarcinoma (PDAC) using neoadjuvant chemoradiotherapy, chemotherapy, and immunotherapy have had minimal impact on the overall survival of patients. A general lack of immunogenic features and a complex tumor microenvironment (TME) are likely culprits...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ricki T. Krog, Noel F. C. C. de Miranda, Alexander L. Vahrmeijer, Nigel G. Kooreman
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
pancreatic ductal adenocarcinoma
PDAC
induced pluripotent stem cells
iPSCs
cancer models
cancer vaccine
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/c4d760c6828849d491c2f1224e656a40
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/c4d760c6828849d491c2f1224e656a40

Ejemplares similares